The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index; 11 of the 22 sources its claims cite were checked for support.
The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis
Open accessAbstract
The aim of the study was to assess the postpartum risk for glucose intolerance since the introduction of the ‘International Association of Diabetes and Pregnancy Study Groups’ (IADPSG) criteria for gestational diabetes mellitus (GDM). Studies published since 2010 were included, which evaluated the risk for type 2 diabetes mellitus (T2DM), impaired glucose tolerance (IGT), and cardiovascular (CV) events in women with previous GDM compared to normal glucose tolerant women. We included forty-three studies, evaluating 4,923,571 pregnant women of which 5.8% (284,312) had a history of GDM. Five studies used IADPSG criteria (n = 6174 women, 1314 with GDM). The overall pooled relative risk (RR) for postpartum T2DM was 7.42 (95% CI: 5.99–9.19) and the RR for postpartum T2DM with IADPSG criteria was 6.45 (95% CI: 4.74–8.77) compared to the RR of 9.08 (95% CI: 6.96–11.85; p = 0.17) for postpartum T2DM based on other diagnostic criteria. The RR for postpartum IGT was 2.45 (95% CI: 1.92–3.13), independent of the criteria used. None of the available studies with IADPSG criteria evaluated the risk for CV events. Women with a history of GDM based on the IADPSG criteria have a similarly increased risk for postpartum glucose intolerance compared to GDM based on other diagnostic criteria. More studies with GDM based on the IADPSG criteria are needed to increase the quality of evidence concerning the long-term metabolic risk.
Overview
CoChat Summary
TL;DR
In a systematic review and meta-analysis of 43 studies including 4,923,571 pregnant women, prior gestational diabetes mellitus (GDM) was associated with a seven-fold risk of postpartum type 2 diabetes and a two-fold risk of impaired glucose tolerance. Women with GDM diagnosed by the IADPSG criteria had a similarly increased postpartum glucose intolerance risk compared with GDM diagnosed by other criteria.
Key findings
- Overall pooled relative risk (RR) for postpartum type 2 diabetes mellitus (T2DM) was 7.42 (95% CI: 5.99–9.19); for GDM based on IADPSG criteria, RR was 6.45 (95% CI: 4.74–8.77), versus 9.08 (95% CI: 6.96–11.85; p = 0.17) for other diagnostic criteria.
- Overall pooled RR for postpartum impaired glucose tolerance (IGT) was 2.45 (95% CI: 1.92–3.13); for IADPSG-based GDM, RR was 2.79 (95% CI: 1.30–5.96), versus 2.03 (95% CI: 1.57–2.62; p = 0.73) for other criteria.
- Cardiovascular outcomes were reported in five studies: RR for stroke was 1.23 (95% CI: 1.09–1.38) and RR for myocardial infarction was 1.85 (95% CI: 1.53–2.24); none of these studies used IADPSG criteria.
- Sensitivity analyses found higher RRs among good-quality studies: T2DM RR 15.21 (95% CI: 8.36–27.69) and IGT RR 4.57 (95% CI: 2.13–9.80), while prospective cohort studies showed T2DM RR 4.41 (95% CI: 3.64–5.35) and IGT RR 2.41 (95% CI: 1.87–3.10).
Methods
- Systematic review and meta-analysis registered in PROSPERO (CRD42018102315), reported per MOOSE, searching MEDLINE, EMBASE, Web of Science, Cochrane Library, and LILACS up to 20 January 2019 for studies published after 2009.
- Included 43 studies: 40 on T2DM, 21 on IGT, and 5 on cardiovascular events; total 4,923,571 pregnant women, of whom 284,312 (5.8%) had GDM. Five studies used IADPSG criteria (n = 6174 women, 1314 with GDM).
- Pooled analyses used RevMan 5.3 with DerSimonian and Laird random-effects models and Mantel–Haenszel methods; heterogeneity assessed with Cochran Q and I², with subgroup and sensitivity analyses, and quality assessed by Newcastle–Ottawa Scale.
Limitations
- The paper states: language restriction to English, French, and Spanish led to exclusion of one Chinese-language study; BMI and family history data were often missing; overall study quality was low, often due to lack of a matched control group; nearly one-third of studies did not report GDM diagnostic criteria; only five studies used IADPSG criteria and none of the cardiovascular studies did; more IADPSG studies with longer follow-up are needed.
- The text makes evident: substantial heterogeneity was present across subgroups, many subgroup analyses were based on limited numbers of studies, and the majority of studies evaluated Caucasian women, limiting generalizability.
- The text also makes evident that included studies were observational (prospective/retrospective cohorts, case-control, cross-sectional), so residual confounding and differences in screening/follow-up may affect pooled estimates.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The literature search and selection process. N: the number of studies; LILACS: Latin American and Caribbean Health Sciences Literature; T1DM: type 1 diabetes mellitus; T2DM: type 2 diabetes mellitus; GDM: gestational diabetes mellitus; MI: myocardial infarction. * Retrieved from the systematic review of Song et al. [8].](https://figures.cochat.ai/paper-figures/d2ed61d7a32e466d9c43d51b0ea3b4aa/the-risk-for-glucose-intolerance-after-gestational-diabetes-mellitus-since-the-figure-1.jpg)

Verification
Claims the paper makes
6 Valid · 3 Not valid · 9 Not checked · 46 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“A follow-up of the HAPO study 10–14 years postpartum showed that untreated women with GDM, defined post hoc by the IADPSG criteria, had significantly higher rates of a glucose metabolism disorder than women without GDM (52.2% vs. 20.1% (T2DM 10.7% vs. 1.6%)) [11].”
§ The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis > 4. Discussion > 4.2. Results in Relation to What We Already Know
What the sources say
- Supportedcites [11] Lowe, 2018, Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity, JAMA source
The Secondary Outcomes section of our copy states exactly the attributed figures: 'Among mothers with gestational diabetes, 10.7% (71/663) had type 2 diabetes ... compared with 1.6% (63/3946) ... among mothers without gestational diabetes,' also tabulated in Table 2. The Primary Independent Variable section confirms GDM was 'defined post hoc using IADPSG criteria,' and the Methods section confirms these women were untreated (results blinded; the 1.8% unblinded above preset thresholds were excluded from the follow-up analyses). The parent sentence's composite disorder-of-glucose-metabolism rates (52.2% vs 20.1%) are likewise stated in the Primary Outcome section. (LLM, conf=0.92)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“We have previously shown glucose intolerance in 42% of women three months after a pregnancy with GDM diagnosed by a two-step screening strategy with a GCT, while less than 20% of women had glucose intolerance in early postpartum after a GDM pregnancy based on a universal one-step diagnostic approach with the IADPSG criteria [9,10].”
§ The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis > 4. Discussion > 4.2. Results in Relation to What We Already Know
What the sources say
- Supportedcites [9] Benhalima, K., Jegers, K., Devlieger, R., Verhaeghe, J., and Mathieu, C. (2016). Glucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria. PLoS ONE, 11. source
The Discussion reports a 19% rate of prediabetes and diabetes in the first year postpartum among Irish women with GDM diagnosed using the 2013 WHO criteria. It also says those studies used a universal one-step 75g OGTT approach. The paper reports this finding from prior studies rather than from its own two-step cohort. (LLM, conf=0.90)
- Supportedcites [10] Benhalima, K., Van Crombrugge, P., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., and de Block, C. (2019). Prediction of Glucose Intolerance in Early Postpartum in Women with Gestational Diabetes Mellitus Based on the 2013 WHO Criteria. J. Clin. Med., 8. source
The Results (section 3.1) report glucose intolerance in 18.2% (35/192) of women tested about 14 weeks postpartum after GDM. The Discussion identifies this cohort as diagnosed through a universal one-step strategy using the 2013 WHO criteria, which the Introduction describes as IADPSG/2013 WHO criteria. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In general, the IADPSG screening strategy identifies women with milder degrees of hyperglycemia during pregnancy compared to other diagnostic criteria and screening strategies (two-step or selective screening), which might lead to a lower proportion at risk of postpartum glucose intolerance [9,10,11].”
§ The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis > 4. Discussion > 4.2. Results in Relation to What We Already Know
What the sources say
- Partly supportedcites [9] Benhalima, K., Jegers, K., Devlieger, R., Verhaeghe, J., and Mathieu, C. (2016). Glucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria. PLoS ONE, 11. sourceExperimental — accuracy not yet measured
The Discussion of Benhalima et al. (2016) states almost verbatim the hedged core of the claim: 'The use of the 2013 WHO criteria for GDM results in a greater proportion of women diagnosed with mild forms of GDM which might presumably lead to a lower proportion at risk for postpartum glucose intolerance' (Introduction similarly notes 'uncertainty on the risk of women who have had mild GDM to develop T2DM postpartum'). However, the source does not support the comparative extension to 'other screening strategies (two-step or selective screening)': in the same Discussion it argues the opposite for the two-step route, that a universal two-step strategy with a GCT 'might identify women at higher risk for the development of glucose intolerance postpartum' because those women fail both GCT and OGTT, and it reports 'similar high rates of glucose intolerance with the 2013 WHO criteria as with the Carpenter and Coustan criteria in early postpartum' (42.2% prediabetes, 1.5% overt diabetes). So the milder-hyperglycaemia attribution is made for the 2013 WHO/IADPSG criteria versus older criteria (1999 WHO, Carpenter and Coustan), not versus two-step or risk-factor-based selective screening. (LLM, conf=0.78)
- Partly supportedcites [10] Benhalima, K., Van Crombrugge, P., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., and de Block, C. (2019). Prediction of Glucose Intolerance in Early Postpartum in Women with Gestational Diabetes Mellitus Based on the 2013 WHO Criteria. J. Clin. Med., 8. sourceExperimental — accuracy not yet measured
The Introduction (p. 1) and Discussion (Section 4) of Benhalima et al. 2019 state verbatim what the claim's second half attributes: 'The use of the 2013 WHO criteria for GDM results in a greater proportion of women who are diagnosed with mild forms of GDM, which might lead to a lower proportion at risk for postpartum glucose intolerance compared to women diagnosed with GDM by a two-step screening strategy', reinforced by their own data (18.2% glucose intolerance postpartum after universal one-step screening vs. 42% previously after a two-step strategy). The hedged 'might' is preserved in the citing sentence. However, the source's comparison is confined to the two-step screening strategy; it says nothing about 'selective screening' or about 'other diagnostic criteria' generally, so that widening of the comparator is not supported by this paper. Our copy also contains no passage attributing to IADPSG specifically the identification of 'milder degrees of hyperglycemia during pregnancy' — it speaks of mild forms of GDM under the 2013 WHO criteria. (LLM, conf=0.72)
- Partly supportedcites [11] Lowe, 2018, Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity, JAMA sourceExperimental — accuracy not yet measured
The HAPO Follow-up paper (JAMA 2018) supports the core of the attribution: the Discussion states that 'a larger population of women with lesser degrees of hyperglycemia (ie, IADPSG-defined gestational diabetes) were at risk for progression to prediabetes and type 2 diabetes,' and the exploratory IADPSG-vs-Carpenter-Coustan section plus Table 4 show outcome frequencies for a maternal disorder of glucose metabolism rising progressively across no GDM (20.0%), IADPSG-only GDM (47.2%) and Carpenter-Coustan GDM (68.4%), i.e. a lower proportion affected in the milder IADPSG-identified group. However, the source makes this comparison only against the Carpenter-Coustan (two-step) criteria, not against 'selective screening,' and it does not frame its findings as a consequence of adopting one screening strategy over another; on the contrary it cautions that 'the risks for the large group of women meeting the IADPSG-defined criteria... were substantial and cannot be ignored from a public health perspective.' The extension to selective screening and the screening-strategy framing are therefore not supported by this source. (LLM, conf=0.72)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, GDM, according to the CC criteria, was associated with a much higher risk for T2DM (20% vs. 7.9%) compared to women with GDM according to the IADPSG criteria alone [11].”
§ The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis > 4. Discussion > 4.2. Results in Relation to What We Already Know
What the sources say
- Supportedcites [11] Lowe, 2018, Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity, JAMA source
Table 4 (exploratory analyses of outcome frequencies) reports type 2 diabetes in 31/155 (20.0%) of mothers with Carpenter-Coustan-defined GDM vs 40/508 (7.9%) of those meeting IADPSG but not Carpenter-Coustan criteria (i.e., IADPSG-defined 'alone', as defined in the Methods, 'IADPSG vs Carpenter-Coustan Criteria for Gestational Diabetes'), against 1.6% of mothers without GDM. The Discussion states that 'Gestational diabetes according to the Carpenter-Coustan criteria as defined in this study was linked to higher outcome risks,' so both the direction and the two percentages in the claim come from this paper. The only qualification the citing sentence drops is that these were unadjusted χ² exploratory comparisons and the study was not designed to compare Carpenter-Coustan vs IADPSG definitions. (LLM, conf=0.90)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In general, the IADPSG screening strategy identifies women with milder degrees of hyperglycemia during pregnancy compared to other diagnostic criteria and screening strategies (two-step or selective screening), which might lead to a lower proportion at risk of postpartum glucose intolerance [9,10,11].”
§ The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis > 4. Discussion > 4.2. Results in Relation to What We Already Know
What the sources say
- Partly supportedcites [9] Benhalima, K., Jegers, K., Devlieger, R., Verhaeghe, J., and Mathieu, C. (2016). Glucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria. PLoS ONE, 11. sourceExperimental — accuracy not yet measured
The Introduction says the IADPSG/2013 WHO criteria diagnose a greater proportion of women with mild GDM, and the Discussion contrasts mild GDM detected by OGTT alone with women identified through two-step screening. The paper does not establish that IADPSG screening identifies milder hyperglycemia than selective screening; it says that comparison was still being evaluated. Its own cohort used the 2013 WHO criteria within a two-step strategy. (LLM, conf=0.85)
- Partly supportedcites [10] Benhalima, K., Van Crombrugge, P., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., and de Block, C. (2019). Prediction of Glucose Intolerance in Early Postpartum in Women with Gestational Diabetes Mellitus Based on the 2013 WHO Criteria. J. Clin. Med., 8. sourceExperimental — accuracy not yet measured
The Introduction and Discussion (page numbers unavailable) say the one-step 2013 WHO approach diagnoses a greater proportion of women with mild GDM and compare its postpartum risk with two-step screening. They do not establish the claimed comparison with selective screening or other diagnostic criteria. (LLM, conf=0.84)
- Partly supportedcites [11] Lowe, 2018, Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity, JAMA sourceExperimental — accuracy not yet measured
The Abstract says IADPSG criteria diagnose about twice as many women as the two-step Carpenter–Coustan criteria, and the Discussion describes the additional IADPSG-defined group as having lesser degrees of hyperglycemia. Our copy does not compare IADPSG with selective screening, so that part of the claim is unsupported. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
39 more claims
Create a free account to see all 64 claims and to verify the 11 references still open.
- Probably not a substantial claim. 11
- It may state two separate claims as one. 12
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Women with GDM have a much higher risk of developing impaired glucose tolerance and T2DM in later life than women with uncomplicated pregnancies7,195–201”
From A global view of hypertensive disorders and diabetes mellitus during pregnancy (2022) · cites this paper as [198]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis > 2. Methods > 2.3. Study Selection
“No language restriction was applied, but studies written in languages other than English, French, or Spanish were only included if they could be adequately translated using Google Translate.”
§ The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis > 4. Discussion > 4.4. Strengths and Limitations
“Due to the language barrier, we only searched studies published in English, French, and Spanish.”
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“Heterogeneity was assessed using the Cochran Q statistic and quantified using the I2 statistic, where I2 > 50% was considered as important heterogeneity [13].”
MethodDermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
(2014) · Medical Entomology and Zoology · Cited by 17,633
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253 · cited 9×
“In contrast to other systematic reviews, our review included only recent studies published after 2009, and we did not only include cohort studies but also case-control and cross-sectional studies provided they met the eligible criteria [2,8].”
BackgroundMethodResultInfluentialMetzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Kramer, C. K., Campbell, S., & Retnakaran, R. (2019) · Diabetologia · doi:10.1007/s00125-019-4840-2 · Cited by 965 · cited 3×
“2018 [56] Retrospective cohort study, Canada NR NR NR NR NR No matched controls NR”
BackgroundResultInfluential
Cited by
A global view of hypertensive disorders and diabetes mellitus during pregnancy
Jiang, L., Tang, K., Magee, L. A., von Dadelszen, P., Ekeroma, A., Li, X., Zhang, E., & Bhutta, Z. A. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00734-y · Cited by 314
Pathophysiology from preconception, during pregnancy, and beyond.
Hivert, M.-F., Backman, H., Benhalima, K., Catalano, P., Desoye, G., Immanuel, J., McKinlay, C. J. D., Meek, C. L., Nolan, C. J., Ram, U., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00827-4 · Cited by 186
Self-citationBenhalima, K., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., Block, C. E. M. D., et al. (2020) · Acta Diabetologica · doi:10.1007/s00592-019-01469-5 · Cited by 60
Self-citationAn Update on Screening Strategies for Gestational Diabetes Mellitus: A Narrative Review
Minschart, C., Beunen, K., & Benhalima, K. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s287121 · Cited by 48
Self-citationBenhalima, K., Geerts, I., Calewaert, P., Rijsselberghe, M. V., Lee, D., Bochanen, N., Verstraete, S., Buyse, L., Lewi, L., Caron, R., et al. (2024) · Acta Clinica Belgica · doi:10.1080/17843286.2024.2384258 · Cited by 38
“By diagnosing GDM, a group of women (and their offspring) at high risk to develop T2DM and cardiovascular disease later in life is identified [5,32].”
Self-citation
Metadata
- Authors
- Benhalima, K., Lens, K., Bosteels, J., & Chantal, M.
- Affiliations
- KU Leuven (BE)
- Imelda Hospital (BE)
- Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
- Corresponding author
- Benhalima, Katrien
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2019-09-10
- Volume
- 8
- Issue
- 9
- Pages
- 1431
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC6780861
- OpenAlex
- W2972681874
- Cited by
- 50
- References
- 59
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 6 · 2023: 4 · 2022: 7 · 2021: 12 · 2020: 8
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fonds Wetenschappelijk Onderzoek
- Vlaamse regering
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, postpartum glucose intolerance, type 2 diabetes, impaired glucose tolerance, IADPSG criteria, cardiovascular events, diagnostic criteria comparison
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.3390/jcm8091431
- The paper
- Benhalima, K., Lens, K., Bosteels, J., & Chantal, M. (2019). The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. https://doi.org/10.3390/jcm8091431
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.